This study aims to evaluate the expression of pro-anti-inflammatory proteins LIF and p53 on fetal lung tissues exposed to chorioamnionitis during three different stages of fetal lung development. Moreover, the interaction between LIF and p53 on inflammatory lung tissue will also be evaluated. The gene discussed is LIF; the disease is chorioamnionitis.